U.S. Sleep Apnea Devices Market Expected to lead the Global Market in Coming Years

William Kellogg
March 4, 2019

Apnea is a disorder that occurs when the body and brain receive insufficient oxygen and breathing process is interpreted during sleep. Obstructive Sleep Apnea (OSA) is the most generic form of apnea known to be caused by airway blockage. There have been several rising incidents of sleep disorders which has resulted in the growth of the apnea devices market across the world. There have been incidents of Obstructive Sleep Apnea (OSA) and associated issues such as stroke and atrial fibrillation. The rise in the presence of OSA is attributed to the reduction in the size of the upper airway lumen due to increasing age factor. Type-2 diabetes, as well as depression in OSA patients,  are also rapidly growing which has urged the government bodies and private firms to invest more in the research and development of sleep apnea devices. Another factor aiding the industry growth is the rapid advancements in technology for sleep apnea devices as well as the growing aging population across the world which are more prone to sleep disorders.

Sleep Apnea Device market is segmented by product and end-user. By product, the sleep apnea device market is segmented into therapeutic and diagnostic sleep apnea devices. The therapeutic device is further sub-divided into positive airway pressure(PAP) devices, facial interfaces (masks), accessories, oral appliances, and other therapeutic devices such as oxygen concentrators and airway clearance systems. The primary users of Sleep Apnea Devices include sleep clinics and laboratories or at people’s home. In 2016-2018, the demand for the therapeutic devices was five times more than that of diagnostic devices, since apnea is a common and mostly harmless disorder, as known to most people. However, these instruments are being used a lot at sleep clinics than they are used at home, which indicates that patients still are not entirely attentive to the causes and therefore consider the steering and direction of doctor’s vital in managing it.

The global apnea device market is estimated to reach $6.49 Billion by 2023 from an approximated $4.44 Billion in 2018, at a CAGR of 7.8% during the forecast period. Growth in the Sleep Apnea Devices Market could be associated with common issues such as the global increment of sleep apnea owing to the increase of lifestyle diseases such as obesity, initiatives by market players. It has expanded awareness regarding sleep apnea by the government and the various Technological advancements by the players to make the products comfortable for patients and therefore, increasing adherence and compliance of the patient to the treatment.

There’s been a considerable number of people which have looked towards wearable sleep apnea tracking devices that measure the blood pressure, heart rate, respiration rate, and oxygen saturation, making it easier for doctor’s diagnostics. There has been an increase in home sleep testing devices as they are mon to be non-invasive and come with in-built electroencephalography (EEG) feature.

North America led the sleep apnea devices market during 2016-2018 due to the increasing cases of obesity in the US, the high growth of the home sleep testing devices, awareness-raising campaigns, and technological advancements in devices. By 2023, the U.S is estimated to have the largest users of sleep apnea devices.

The Asia-Pacific region, especially Japan will witness the highest market growth globally, Factors influencing the growth of this region include increasing prevalence of sleep apnea disorders, undiagnosed pool in countries such as India, and initiatives by the government and other private organizations to raise awareness regarding sleep disorder.

The Middle East and Africa hold the smallest share within the global apnea device market due to their stringent government policies and poor economies.

William Kellogg

William Kellogg is a veteran writer who's covered the subject of the intersection of technology, health and mental wellness for nearly two decades.

More For You